Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oncor technology covered by U.S. patent

Jan. 24, 1997

Collaborators sought for gene therapy technology

Jan. 23, 1997

NIH seeks licensees for perilipins

Jan. 23, 1997

New tool for studying phosphodiesterase receptors

Jan. 23, 1997

ArQule and Abbott extend collaboration

Jan. 22, 1997

NIH offers sterile lyophilization product

Jan. 22, 1997

TheraTech licenses pulmonary delivery devices

Jan. 22, 1997

Hybridon granted patent coverage for orally administered hybrid compounds

Jan. 21, 1997

Forbes files for U.S. patent related to membrane deficiencies

Jan. 20, 1997

IDEC licenses technology to Boehringer Ingelheim

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...